Your browser doesn't support javascript.
loading
Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides.
Hu, Yue; Zhu, Yuanmei; Yu, Yanying; Liu, Nian; Ju, Xiaohui; Ding, Qiang; He, Yuxian.
  • Hu Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
  • Zhu Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
  • Yu Y; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, 100084, China.
  • Liu N; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
  • Ju X; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, 100084, China.
  • Ding Q; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, 100084, China. Electronic address: qding@tsinghua.edu.cn.
  • He Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. Electronic address: yhe@ipb.pumc.edu.cn.
Antiviral Res ; 212: 105571, 2023 04.
Article en En | MEDLINE | ID: mdl-36868315
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article